Fenichel P, Donzeau M, Cervoni F, Menezo Y, Hsi B L
INSERM U364, Faculté de Médecine, Nice, France.
Am J Reprod Immunol. 1995 Feb;33(2):155-64. doi: 10.1111/j.1600-0897.1995.tb00879.x.
To investigate the relation between the complement system and reproduction, expression of complement regulatory proteins (C3b receptors and inhibitor of the membrane attack complex) were screened on unfixed human eggs and preimplantation embryos.
Unfixed unfertilized oocytes and preimplantation embryos obtained from an in vitro fertilization program were stained by indirect immunofluorescence using monoclonal antibodies raised against membrane cofactor protein, (MCP or CD46), decay accelerating factor (DAF or CD55), protectin (CD59), human C3b/C4b receptor (CR1 or CD35), and major histocompatibility complex class I antigen (MHC class I).
CD55 and CD59 were both expressed by the plasma membrane of unfertilized oocytes and pre-implantation embryos. CD46 was not expressed by unfertilized oocytes but appeared at the 6-to-8 cell stage embryo when human gene expression first occurs. CD35 and MHC class I antigens were not expressed at all on oocytes and preimplantation embryos.
Selective expression of complement regulatory proteins (DAF and protectin) associated with the lack of MHC class I antigens may represent an immune protective mechanism by which human oocytes and preimplantation embryos escape complement-mediated damage during their travel through the female genital tract. Furthermore, participation of these complement regulatory proteins including MCP in cell to cell interaction during fertilization and/or implantation cannot be excluded.
为研究补体系统与生殖之间的关系,对未固定的人类卵子和植入前胚胎上补体调节蛋白(C3b受体和膜攻击复合物抑制剂)的表达进行筛选。
从体外受精程序中获取的未固定未受精卵母细胞和植入前胚胎,使用针对膜辅因子蛋白(MCP或CD46)、衰变加速因子(DAF或CD55)、保护素(CD59)、人C3b/C4b受体(CR1或CD35)和主要组织相容性复合体I类抗原(MHC I类)的单克隆抗体,通过间接免疫荧光进行染色。
未受精卵母细胞和植入前胚胎的质膜均表达CD55和CD59。未受精卵母细胞不表达CD46,但在人类基因表达首次出现的6至8细胞期胚胎时出现。卵母细胞和植入前胚胎上完全不表达CD35和MHC I类抗原。
与缺乏MHC I类抗原相关的补体调节蛋白(DAF和保护素)的选择性表达,可能代表一种免疫保护机制,通过该机制人类卵母细胞和植入前胚胎在通过女性生殖道的过程中逃避补体介导的损伤。此外,不能排除这些补体调节蛋白(包括MCP)在受精和/或植入过程中的细胞间相互作用中发挥作用。